Michel Dubois
Director/Board Member at GENEURO SA
Network origin in Michel Dubois first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
18
| Public Company | Biotechnology | 18 |
| Public Company | Biotechnology | 8 | |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The private company is based in Lyon, France.
3
| Subsidiary | Biotechnology | 3 |
Centre Hospitalier Saint Joseph - Saint Luc
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michel Dubois via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Geneva | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director/Board Member Sales & Marketing | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
| Institut de Pharmacie Industrielle de Lyon | College/University | Director/Board Member Graduate Degree | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Value Management Group LLC
 Value Management Group LLC Miscellaneous Commercial ServicesCommercial Services Value Management Group LLC engages in the provision of healthcare valuation and advisory services. It offers physician compensation valuation and value-based arrangements, real estate appraisal, capital asset appraisal, financial due diligence, litigation and dispute resolution, compensation plan design and consulting, and other healthcare transaction advisory. The company was founded by Greg Koonsman in 1995 and is headquartered in Dallas, TX. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| Transgene, Inc. | Director/Board Member Director/Board Member | ||
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member President | |
| ESSEC Business School | College/University | Masters Business Admin Undergraduate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Undergraduate Degree | |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Chairman | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| Aventis, Inc. | Chief Tech/Sci/R&D Officer | ||
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Servier CJSC
 Servier CJSC Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The private company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EM Lyon Business School | College/University | Masters Business Admin | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Servier Laboratories
 Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ecole Nationale Vétérinaire de Nantes | College/University | Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
| Queen's School of Medicine | College/University | Graduate Degree | |
Servier IP UK Ltd.
 Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a private company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Medical Distributors | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
NTC SRL
 NTC SRL Pharmaceuticals: GenericHealth Technology NTC SRL manufactures generic drugs, nutraceutical and pharmaceutical products. It develops and produces generic drugs for specialist therapies, innovative medical devices and high quality food supplements. The company was founded by Nicola Travierso in 1997 and is headquartered in Milan, Italy. | Pharmaceuticals: Generic | Director/Board Member | |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Peptomyc SL
 Peptomyc SL Pharmaceuticals: MajorHealth Technology Peptomyc SL develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment. The company was founded by Marie-Eve Beaulieu and Laura Soucek on December 16, 2014 and is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Chairman | |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member | |
| Handicap International France | Director/Board Member | ||
| INNATE PHARMA | Pharmaceuticals: Major | Founder |
Statistics
International
| France | 19 |
| United States | 13 |
| Italy | 6 |
| Switzerland | 5 |
| China | 3 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Health Services | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 120 |
| Corporate Officer/Principal | 61 |
| Chairman | 35 |
| Independent Dir/Board Member | 25 |
| Chief Executive Officer | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Michel Gréco | 28 |
| Philippe Archinard | 24 |
| Jean Bizzari | 24 |
| Henri Saint-Olive | 20 |
| Jesús Martin-Garcia | 20 |
| Jean-François Labbé | 18 |
| Giacomo di Nepi | 16 |
| Margaret Liu | 15 |
| Hedi Brahim | 13 |
| Miguel Payró | 12 |
| Georges Hibon | 10 |
| Eric Falcand | 10 |
| Pascal Neuville | 9 |
| Robert Glanzman | 8 |
| Thibaut du Fayet | 8 |
- Stock Market
- Insiders
- Michel Dubois
- Company connections
